218 related articles for article (PubMed ID: 12369119)
1. Halting the progression of renal disease: where we stand?
Campbell RC; Remuzzi G
Nefrologia; 2002; 22(4):303-5. PubMed ID: 12369119
[No Abstract] [Full Text] [Related]
2. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria, a modifiable risk factor: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs).
Dykeman-Sharpe J
CANNT J; 2003; 13(4):34-6; quiz 37-8. PubMed ID: 14753101
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
[No Abstract] [Full Text] [Related]
5. Management of hypertension in patients with chronic kidney disease and diabetes mellitus.
Palmer BF
Am J Med; 2008 Aug; 121(8 Suppl):S16-22. PubMed ID: 18638614
[TBL] [Abstract][Full Text] [Related]
6. Progression of chronic kidney disease: can it be prevented or arrested?
Jaber BL; Madias NE
Am J Med; 2005 Dec; 118(12):1323-30. PubMed ID: 16378772
[TBL] [Abstract][Full Text] [Related]
7. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
9. REIN on obesity, proteinuria and CKD.
Choi ME
J Am Soc Nephrol; 2011 Jun; 22(6):990-2. PubMed ID: 21617125
[No Abstract] [Full Text] [Related]
10. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
11. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
Weir MR
Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
Maione A; Strippoli GF
Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
[TBL] [Abstract][Full Text] [Related]
14. Which antihypertensive drugs are the most nephroprotective and why?
Cravedi P; Ruggenenti P; Remuzzi G
Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
Bakris GL; Weir MR
Postgrad Med; 2008 Apr; 120(1):33-42. PubMed ID: 18467807
[TBL] [Abstract][Full Text] [Related]
16. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular disease in kidney transplantation].
Marcén R; Pascual J
Nefrologia; 2001; 21(2):104-14. PubMed ID: 11464644
[No Abstract] [Full Text] [Related]
18. [Inhibition of the renin-angiotensin system to prevent target organ damage: the "renal continuum"].
Tislér A
Orv Hetil; 2003 May; 144(18 Suppl 1):898-901. PubMed ID: 12785234
[TBL] [Abstract][Full Text] [Related]
19. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
Griffin KA; Bidani AK
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
